Amazfit Introduces Balance 2 Smartwatch and Helio Strap for Smarter Training, Better Recovery and Peak Performance
Article content
MILPITAS, Calif. — Amazfit, a leading global smart wearable brand owned by Zepp Health (NYSE: ZEPP), a health technology company, today announced the launch and availability of two new performance-focused devices—the Balance 2 smartwatch and the Helio Strap, Amazfit's first screen-free fitness, recovery, and sleep tracker.
Article content
Combined, the Balance 2 and the Helio Strap deliver accuracy in heart rate monitoring, fatigue assessment, and recovery analysis.
Article content
Better Together: A Smarter Training and Recovery System
Article content
While both devices can be purchased and used individually, it's their combined potential as an all-in-one training and recovery system that truly sets them apart. Balance 2 is a premium multisport training partner that gives users access to advanced performance tracking. When paired with the Helio Strap, the system delivers even greater accuracy in heart rate monitoring, fatigue assessment, and recovery analysis. All data syncs effortlessly within the Zepp App, providing a unified ecosystem and experience across all Amazfit devices—no additional apps or subscriptions required.
Article content
Balance 2: The Premium Multisport Training Partner
Article content
Built for high performers, the new Amazfit Balance 2 supports daily training across multiple sports — perfect for hybrid athletes and anyone balancing gym workouts, strength training, running, cycling, golf, diving, and more. With intelligent tracking, personalized insights, and a design that transitions effortlessly from intense training sessions to workdays and weekend outings, Balance 2 empowers users to excel in every moment. ($299.99 USD; €299.9 euro)
Article content
Key Features:
Article content
￮ Durability and Performance: Scratch-resistant 1.5-inch Sapphire glass screen with an AMOLED display and up to 2000 nits of brightness for excellent visibility in any lighting and sustained performance, plus 10 ATM water resistance and 21-day battery life.
Article content
￮ HYROX-Optimized Training: As the Official Timekeeper of HYROX, Amazfit is the first—and only—brand with three dedicated HYROX modes. Specifically designed to support the demands of structured HYROX workouts, it lets users plan intervals, heart rate zones, transitions, and recovery—then track and analyze it all in the Zepp App for smarter performance and faster recovery.
Article content
￮ Enhanced Monitoring: More accurate monitoring of key biometrics, including exercise heart rate, HRV, blood oxygen level, sleep patterns and more.
Article content
￮ Free Downloadable Maps ideal for both city running and weekend adventures.
Article content
￮ Advanced Golf Features: Amazfit's first smartwatch with a full in-round golf experience—40K+ course maps, pin relocation, hazards, scoring, and swing feedback like swing plane and tempo. With golf now built in, Balance 2 is an all-in-one watch for work, workouts, and the course—no separate golf watch needed.
Article content
￮ Dedicated Diving Support: With 100-meter water resistance, Balance 2 supports both freediving and scuba diving up to 45 meters, enabling accurate tracking and enhanced safety for underwater performance.
Article content
￮ 170+ Sport Modes, including running, swimming, strength training, HIIT, pickleball, and more.
Article content
￮ All-New BioCharge™ Score (Coming soon): A personalized body energy management feature that continuously analyzes energy levels in real time by integrating data from sleep, naps, exertion, and stress helping users balance activity and recovery for better performance.
Article content
Helio Strap: Screen-Free, Distraction-Free, Subscription-Free Performance Tracking
Article content
Helio Strap is Amazfit's first screen-free tracker designed to deliver fitness, sleep, and recovery data with exceptional comfort and no distractions. Ideal for athletes of all levels, Helio Strap captures advanced metrics and offers the freedom to train smarter and recover better—all with no subscription required. It pairs seamlessly with Amazfit smartwatches, including Balance 2, Helio Ring, and the Zepp App. ($99.99 USD; €99.9 euro)
Article content
Key Features:
Article content
￮ 10-Day Battery Life: Train, recover, and repeat without missing a beat. The Helio Strap can last up to 10 days from a single charge.
Article content
￮ Continuous Heart Rate Monitoring: Delivers high-precision heart rate tracking 24/7, enabling users to better understand training load, recovery status, and overall cardiovascular health—all without needing to check a screen or interrupt their routine.
Article content
￮ 27 Workout Modes accessible through the Zepp App, each tailored to capture key performance metrics and optimize training across a wide range of activities—including running, walking, cycling, and indoor gym workouts like strength training, HIIT, yoga, and more.
Article content
￮ Strength Training & HYROX Modes: Advanced strength training features with detailed tracking for reps, sets, and rest periods, plus exclusive HYROX Race Mode with race-specific and benchmark training tools.
Article content
￮ All-New BioCharge™ Score: Available now on Helio Strap, BioCharge is a personalized body energy management feature that continuously analyzes energy levels in real time by integrating data from sleep, naps, exertion, and stress helping users balance activity and recovery for better performance.
Article content
'Through a single app, these two devices work seamlessly together—whether it's during training or recovery monitoring. Each one complements and fills in the gaps of the other, enabling more accurate, cross-referenced data. This means more precise insights for the user, all within one simple, unified system,' said Wayne Huang, CEO of Zepp Health. 'With no subscriptions, advanced tracking, and effortless syncing, this duo redefines what wearables can do—whether you're a competitive athlete or simply striving to be your best.'
Article content
Availability and Pricing
Article content
The Amazfit Balance 2 smartwatch will be available for $299.99 USD; €299.9 euro, while the Helio Strap will retail for $99.99 USD; €99.9 euro —both launching globally on June 24 via Amazfit.com, Amazon, and select retailers. For users seeking the ultimate performance and recovery solution, the Balance 2 + Helio Strap bundle will be offered at a special price of $379.99 USD.
Article content
About Amazfit
Article content
Amazfit, a leading global smart wearable brand focused on health and fitness, is part of Zepp Health (NYSE: ZEPP), a health technology company with its principal office based in Gorinchem, the Netherlands. Zepp Health operates as a distributed organization, with team members and offices across the Americas, Europe, Asia, and other global markets.
Article content
Offering a wide selection of smartwatches and bands, Amazfit's brand tagline, 'Discover Amazing,' encourages individuals to break barriers, exceed expectations, and find joy in every moment. Amazfit is powered by Zepp Health's proprietary health management platform, which delivers cloud-based, 24/7 actionable insights and guidance to help users achieve their wellness goals.
Article content
Known for outstanding craftsmanship, Amazfit smartwatches have won numerous design awards, including the iF Design Award and the Red Dot Design Award. Launched in 2015, Amazfit is embraced by millions of users, with products available in over 90 countries across the Americas, EMEA, and APAC regions. For more information, visit www.amazfit.com.
Article content
Article content
Article content
Article content
Article content
Contacts
Article content
Media Contact
Article content
Article content
Article content
Article content
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
2 hours ago
- Globe and Mail
Microsoft Stock (MSFT) Hits All-Time High as AI Trade Comes Roaring Back
Microsoft's (MSFT) stock is at an all-time high on June 27 and on the cusp of breaking above $500 a share as the artificial intelligence (AI) trade comes roaring back. Confident Investing Starts Here: MSFT stock was trading at $499.30 at noon hour and could close above $500 a share on a split adjusted basis. The current rally coming off April lows has pushed Microsoft's share price up 19% this year and put its market capitalization at $3.70 trillion, second only to Nvidia (NVDA) at $3.84 trillion. Analysts and traders on Wall Street are now debating which technology giant will be the first to reach a $4 trillion market cap, Microsoft or Nvidia. Several analyst have also been raising their ratings and price targets on MSFT stock during its current bull run. Wedbush tech analyst Daniel Ives recently raised his price target on Microsoft's shares to $600 from $515 while reiterating a Buy rating on the stock. Bullish Sentiment Analysts and investors are turning increasingly bullish on Microsoft as sentiment towards artificial intelligence (AI) again turns positive. The Seattle-based technology giant's share price has also been rising since the company reported strong first-quarter financial results in May that showed hefty growth in the Azure cloud computing unit. More recently, reports have surfaced that the Windows maker is planning to cut thousands of jobs as it looks to reduce its labor costs while increasing its AI spending. Microsoft is seen as a leader in generative AI and is cascading the technology across its various business segments and consumer-facing products. Is MSFT Stock a Buy? Microsoft's stock has a consensus Strong Buy rating among 35 Wall Street analysts. That rating is based on 30 Buy and five Hold recommendations issued in the last three months. The average price target on MSFT stock of $521.41 implies 4.71% upside from current levels. Disclaimer & Disclosure Report an Issue
Globe and Mail
6 hours ago
- Globe and Mail
Robert W. Baird Keeps Their Hold Rating on Tesla (TSLA)
In a report released today, Ben Kallo from Robert W. Baird reiterated a Hold rating on Tesla (TSLA – Research Report), with a price target of $320.00. The company's shares opened today at $342.70. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Kallo is an analyst with an average return of -1.6% and a 43.26% success rate. Kallo covers the Consumer Cyclical sector, focusing on stocks such as Tesla, Rivian Automotive, and QuantumScape. Tesla has an analyst consensus of Hold, with a price target consensus of $287.00, which is a -16.25% downside from current levels. In a report released on June 20, Barclays also maintained a Hold rating on the stock with a $275.00 price target. TSLA market cap is currently $1121.5B and has a P/E ratio of 187.24. Based on the recent corporate insider activity of 51 insiders, corporate insider sentiment is neutral on the stock. Earlier this month, Xiaotong Zhu, the SVP, APAC of TSLA sold 15,000.00 shares for a total of $4,857,000.00.
CTV News
6 hours ago
- CTV News
Many forget the damage done by diseases like whooping cough, measles and rubella. Not these families
Jacque Farnham, 60, left, walks with her mother, Janith, 80, to the Visual Arts Center at the Washington Pavilion in Sioux Falls, S.D., on May 20, 2025. (AP Photo/Shelby Lum) SIOUX FALLS, S.D. — In the time before widespread vaccination, death often came early. Devastating infectious diseases ran rampant in America, killing millions of children and leaving others with lifelong health problems. These illnesses were the main reason why nearly one in five children in 1900 never made it to their fifth birthday. Over the next century, vaccines virtually wiped out long-feared scourges like polio and measles and drastically reduced the toll of many others. Today, however, some preventable, contagious diseases are making a comeback as vaccine hesitancy pushes immunization rates down. And well-established vaccines are facing suspicion even from public officials, with Robert F. Kennedy Jr., a longtime anti-vaccine activist, running the federal health department. 'This concern, this hesitancy, these questions about vaccines are a consequence of the great success of the vaccines – because they eliminated the diseases,' said Dr. William Schaffner, an infectious disease expert at Vanderbilt University Medical Center. 'If you're not familiar with the disease, you don't respect or even fear it. And therefore you don't value the vaccine.' Anti-vaccine activists even portray the shots as a threat, focusing on the rare risk of side effects while ignoring the far larger risks posed by the diseases themselves — and years of real-world data that experts say proves the vaccines are safe. Some Americans know the reality of these preventable diseases all too well. For them, news of measles outbreaks and rising whooping cough cases brings back terrible memories of lives forever changed – and a longing to spare others from similar pain. Getting rubella while pregnant shaped two lives With a mother's practiced, guiding hand, 80-year-old Janith Farnham helped steer her 60-year-old daughter's walker through a Sioux Falls art center. They stopped at a painting of a cow wearing a hat. Janith pointed to the hat, then to her daughter Jacque's Minnesota Twins cap. Jacque did the same. 'That's so funny!' Janith said, leaning in close to say the words in sign language too. Jacque was born with congenital rubella syndrome, which can cause a host of issues including hearing impairment, eye problems, heart defects and intellectual disabilities. There was no vaccine against rubella back then, and Janith contracted the viral illness very early in the pregnancy, when she had up to a 90 per cent chance of giving birth to a baby with the syndrome. Janith recalled knowing 'things weren't right' almost immediately. The baby wouldn't respond to sounds or look at anything but lights. She didn't like to be held close. Her tiny heart sounded like it purred – evidence of a problem that required surgery at four months old. Janith did all she could to help Jacque thrive, sending her to the Colorado School for the Deaf and the Blind and using skills she honed as a special education teacher. She and other parents of children with the syndrome shared insights in a support group. Meanwhile, the condition kept taking its toll. As a young adult, Jacque developed diabetes, glaucoma and autistic behaviors. Eventually, arthritis set in. Today, Jacque lives in an adult residential home a short drive from Janith's place. Above her bed is a net overflowing with stuffed animals. On a headboard shelf are photo books Janith created, filled with memories like birthday parties and trips to Mount Rushmore. Jacque's days typically begin with an insulin shot and breakfast before she heads off to a day program. She gets together with her mom four or five days a week. They often hang out at Janith's townhome, where Jacque has another bedroom decorated with her own artwork and quilts Janith sewed for her. Jacque loves playing with Janith's dog, watching sports on television and looking up things on her iPad. Janith marvels at Jacque's sense of humour, gratefulness, curiosity and affectionate nature despite all she's endured. Jacque is generous with kisses and often signs 'double I love yous' to family, friends and new people she meets. 'When you live through so much pain and so much difficulty and so much challenge, sometimes I think: Well, she doesn't know any different,' Janith said. Given what her family has been through, Janith believes younger people are being selfish if they choose not to get their children the MMR shot against measles, mumps and rubella. 'It's more than frustrating. I mean, I get angry inside,' she said. 'I know what can happen, and I just don't want anybody else to go through this.' Delaying the measles vaccine can be deadly More than half a century has passed, but Patricia Tobin still vividly recalls getting home from work, opening the car door and hearing her mother scream. Inside the house, her little sister Karen lay unconscious on the bathroom floor. It was 1970, and Karen was 6. She'd contracted measles shortly after Easter. While an early vaccine was available, it wasn't required for school in Miami where they lived. Karen's doctor discussed immunizing the first grader, but their mother didn't share his sense of urgency. 'It's not that she was against it,' Tobin said. 'She just thought there was time.' Then came a measles outbreak. Karen – who Tobin described as a 'very endearing, sweet child' who would walk around the house singing – quickly became very sick. The afternoon she collapsed in the bathroom, Tobin, then 19, called the ambulance. Karen never regained consciousness. 'She immediately went into a coma and she died of encephalitis,' said Tobin, who stayed at her bedside in the hospital. 'We never did get to speak to her again.' Today, all states require that children get certain vaccines to attend school. But a growing number of people are making use of exemptions allowed for medical, religious or philosophical reasons. Vanderbilt's Schaffner said fading memories of measles outbreaks were exacerbated by a fraudulent, retracted study claiming a link between the MMR shot and autism. The result? Most states are below the 95 per cent vaccination threshold for kindergartners — the level needed to protect communities against measles outbreaks. 'I'm very upset by how cavalier people are being about the measles,' Tobin said. 'I don't think that they realize how destructive this is.' Polio changed a life twice One of Lora Duguay's earliest memories is lying in a hospital isolation ward with her feverish, paralyzed body packed in ice. She was three years old. 'I could only see my parents through a glass window. They were crying and I was screaming my head off,' said Duguay, 68. 'They told my parents I would never walk or move again.' It was 1959 and Duguay, of Clearwater, Fla., had polio. It mostly preyed on children and was one of the most feared diseases in the U.S., experts say, causing some terrified parents to keep children inside and avoid crowds during epidemics. Given polio's visibility, the vaccine against it was widely and enthusiastically welcomed. But the early vaccine that Duguay got was only about 80 per cent to 90 per cent effective. Not enough people were vaccinated or protected yet to stop the virus from spreading. Duguay initially defied her doctors. After intensive treatment and physical therapy, she walked and even ran – albeit with a limp. She got married, raised a son and worked as a medical transcriptionist. But in her early 40s, she noticed she couldn't walk as far as she used to. A doctor confirmed she was in the early stages of post-polio syndrome, a neuromuscular disorder that worsens over time. One morning, she tried to stand up and couldn't move her left leg. After two weeks in a rehab facility, she started painting to stay busy. Eventually, she joined arts organizations and began showing and selling her work. Art 'gives me a sense of purpose,' she said. These days, she can't hold up her arms long enough to create big oil paintings at an easel. So she pulls her wheelchair up to an electric desk to paint on smaller surfaces like stones and petrified wood. The disease that changed her life twice is no longer a problem in the U.S. So many children get the vaccine — which is far more effective than earlier versions — that it doesn't just protect individuals but it prevents occasional cases that arrive in the U.S. from spreading further. ' Herd immunity ' keeps everyone safe by preventing outbreaks that can sicken the vulnerable. After whooping cough struck, 'she was gone' Every night, Katie Van Tornhout rubs a plaster cast of a tiny foot, a vestige of the daughter she lost to whooping cough at just 37 days old. Callie Grace was born on Christmas Eve 2009 after Van Tornhout and her husband tried five years for a baby. She was six weeks early but healthy. 'She loved to have her feet rubbed,' said the 40-year-old Lakeville, Indiana mom. 'She was this perfect baby.' When Callie turned a month old, she began to cough, prompting a visit to the doctor, who didn't suspect anything serious. By the following night, Callie was doing worse. They went back. In the waiting room, she became blue and limp in Van Tornhout's arms. The medical team whisked her away and beat lightly on her back. She took a deep breath and giggled. Though the giggle was reassuring, the Van Tornhouts went to the ER, where Callie's skin turned blue again. For a while, medical treatment helped. But at one point she started squirming, and medical staff frantically tried to save her. 'Within minutes,' Van Tornhout said, 'she was gone.' Van Tornhout recalled sitting with her husband and their lifeless baby for four hours, 'just talking to her, thinking about what could have been.' Callie's viewing was held on her original due date – the same day the Centers for Disease Control and Prevention called to confirm she had pertussis, or whooping cough. She was too young for the Tdap vaccine against it and was exposed to someone who hadn't gotten their booster shot. Today, next to the cast of Callie's foot is an urn with her ashes and a glass curio cabinet filled with mementos like baby shoes. 'My kids to this day will still look up and say, 'Hey Callie, how are you?'' said Van Tornhout, who has four children and a stepson. 'She's part of all of us every day.' Van Tornhout now advocates for childhood immunization through the nonprofit Vaccinate Your Family. She also shares her story with people she meets, like a pregnant customer who came into the restaurant her family ran saying she didn't want to immunize her baby. She later returned with her vaccinated four-month-old. 'It's up to us as adults to protect our children – like, that's what a parent's job is,' Van Tornhout said. 'I watched my daughter die from something that was preventable … You don't want to walk in my shoes.' The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content. Laura Ungar, The Associated Press
